The presence of microorganisms in laryngoscopes emphasizes the risk to patient safety during orotracheal intubations.
Methods
A cross-sectional study was carried out in university hospital in the inpatient, emergency, intensive care, and surgical center sectors. Microorganisms were recovered from the blades using a filter membrane and from the handles using swab. They were then sown on blood agar plates and incubated at 35 °C (± 2 °C) for a maximum of 5 days. Microorganisms were identified by mass spectrometry, antimicrobial susceptibility tests were carried out for pathogenic bacteria. Associations were made using χ² and Fisher exact tests, and Poisson regression model.
Results
A total of 158 blades and 45 handles were analyzed. Microbial growth was observed on 59.5% of the blades and 64.4% of the handles, with fungi and bacteria isolated, such as Enterococcus faecium, Staphylococcus aureus, Klebsiella pneumoniae, Acinetobacter baumannii, Pseudomonas aeruginosa, and Enterobacter sp. Multidrug-resistant bacteria, producing extended-spectrum β-lactamases and carbapenemases, were found.
Conclusions
Multidrug-resistant bacteria were found on ready-to-use laryngoscopes. In the surgical center, there was lower probability of microbial growth, while the intensive care sector showed higher probability. This study reinforces the warning that this equipment is a potential source of transmission of microorganisms, especially multiresistant strains.
{"title":"Presence of multidrug-resistant bacteria on ready-to-use laryngoscope blades and handles: A cross-sectional study","authors":"Sara Ester Barbosa MSc , Angelica Zaninelli Schreiber PhD , Eliane Picoli Alves Bensi MSc , Patricia Cristiane Spirlandelli Teixeira BSc , Maria Isabel Pedreira de Freitas PhD , Henrique Ceretta Oliveira PhD , Vanessa Aparecida Vilas-Boas PhD","doi":"10.1016/j.ajic.2024.12.018","DOIUrl":"10.1016/j.ajic.2024.12.018","url":null,"abstract":"<div><h3>Background</h3><div>The presence of microorganisms in laryngoscopes emphasizes the risk to patient safety during orotracheal intubations.</div></div><div><h3>Methods</h3><div>A cross-sectional study was carried out in university hospital in the inpatient, emergency, intensive care, and surgical center sectors. Microorganisms were recovered from the blades using a filter membrane and from the handles using swab. They were then sown on blood agar plates and incubated at 35 °C (±<!--> <!-->2 °C) for a maximum of 5<!--> <!-->days. Microorganisms were identified by mass spectrometry, antimicrobial susceptibility tests were carried out for pathogenic bacteria. Associations were made using χ² and Fisher exact tests, and Poisson regression model.</div></div><div><h3>Results</h3><div>A total of 158 blades and 45 handles were analyzed. Microbial growth was observed on 59.5% of the blades and 64.4% of the handles, with fungi and bacteria isolated, such as <em>Enterococcus faecium</em>, <em>Staphylococcus aureus</em>, <em>Klebsiella pneumoniae</em>, <em>Acinetobacter baumannii</em>, <em>Pseudomonas aeruginosa</em>, <em>and Enterobacter</em> sp. Multidrug-resistant bacteria, producing extended-spectrum β-lactamases and carbapenemases, were found.</div></div><div><h3>Conclusions</h3><div>Multidrug-resistant bacteria were found on ready-to-use laryngoscopes. In the surgical center, there was lower probability of microbial growth, while the intensive care sector showed higher probability. This study reinforces the warning that this equipment is a potential source of transmission of microorganisms, especially multiresistant strains.</div></div>","PeriodicalId":7621,"journal":{"name":"American journal of infection control","volume":"53 4","pages":"Pages 498-505"},"PeriodicalIF":3.8,"publicationDate":"2025-01-04","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143363473","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
In the United States, the system for special pathogen patient care incorporates a network of federally funded US biocontainment units that maintain operational readiness to care for patients afflicted by high-consequence infectious diseases (HCIDs). This network has expanded in number of facilities and in scope, serving as a regional resource for special pathogen preparedness. Lessons learned for maintaining these units are shared with the intent of informing new and existing biocontainment units.
{"title":"Building a biocontainment unit: Infrastructure and organizational experiences of the 13 regional biocontainment units in the United States","authors":"Caroline Persson MPH, CPH, FAPIC , Corri B. Levine PhD, MS, MPH , Kara Marshall MPH , Sophia Shea MPH , Christa Arguinchona MSN, BSN, CCRN , Sharon Vanairsdale Carrasco DNP, APRN, FAEN, FAAN, FNAP , Lauren M. Sauer MSc , Jocelyn J. Herstein PhD, MPH","doi":"10.1016/j.ajic.2024.06.021","DOIUrl":"10.1016/j.ajic.2024.06.021","url":null,"abstract":"<div><div>In the United States, the system for special pathogen patient care incorporates a network of federally funded US biocontainment units that maintain operational readiness to care for patients afflicted by high-consequence infectious diseases (HCIDs). This network has expanded in number of facilities and in scope, serving as a regional resource for special pathogen preparedness. Lessons learned for maintaining these units are shared with the intent of informing new and existing biocontainment units.</div></div>","PeriodicalId":7621,"journal":{"name":"American journal of infection control","volume":"53 1","pages":"Pages 150-153"},"PeriodicalIF":3.8,"publicationDate":"2025-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141537423","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2025-01-01DOI: 10.1016/j.ajic.2024.09.011
So Sato MD , Sachiko Ono DDS, MPH, PhD , Yusuke Sasabuchi MD, MPH, PhD , Kohei Uemura PhD , Hideo Yasunaga MD, PhD
Background
Continuous mumps vaccine coverage is essential for eradicating mumps. However, due to safety concerns, Japan’s mumps vaccination program transitioned from routine to voluntary. To improve coverage, some municipalities introduced subsidization programs, but the effects on vaccination rates and mumps incidence remain unclear.
Methods
In April 2018, a city in Japan launched a subsidization program for the mumps vaccine for children aged 1–6 years. Using vaccination records and healthcare claims from July 2016 to December 2019, we analyzed changes in vaccination coverage and mumps incidence before and after the program’s initiation.
Results
At the program’s start, mumps vaccination coverage among eligible children was 3.3%, increasing by approximately 1.5% monthly to 38.4% after 21 months. Among 308,976 individuals, 145 mumps cases were identified: 92 cases (0.27 per 1,000 person-years) occurred before, and 53 (0.15 per 1,000 person-years) occurred after the program’s start.
Conclusions
Although the mumps vaccination coverage rate increased following the program’s initiation, it remained below the level required for eradication.
{"title":"Changes in the mumps vaccine coverage and incidence of mumps before and after the public subsidization program: A descriptive study using a population-based database in Japan","authors":"So Sato MD , Sachiko Ono DDS, MPH, PhD , Yusuke Sasabuchi MD, MPH, PhD , Kohei Uemura PhD , Hideo Yasunaga MD, PhD","doi":"10.1016/j.ajic.2024.09.011","DOIUrl":"10.1016/j.ajic.2024.09.011","url":null,"abstract":"<div><h3>Background</h3><div>Continuous mumps vaccine coverage is essential for eradicating mumps. However, due to safety concerns, Japan’s mumps vaccination program transitioned from routine to voluntary. To improve coverage, some municipalities introduced subsidization programs, but the effects on vaccination rates and mumps incidence remain unclear.</div></div><div><h3>Methods</h3><div>In April 2018, a city in Japan launched a subsidization program for the mumps vaccine for children aged 1–6 years. Using vaccination records and healthcare claims from July 2016 to December 2019, we analyzed changes in vaccination coverage and mumps incidence before and after the program’s initiation.</div></div><div><h3>Results</h3><div>At the program’s start, mumps vaccination coverage among eligible children was 3.3%, increasing by approximately 1.5% monthly to 38.4% after 21 months. Among 308,976 individuals, 145 mumps cases were identified: 92 cases (0.27 per 1,000 person-years) occurred before, and 53 (0.15 per 1,000 person-years) occurred after the program’s start.</div></div><div><h3>Conclusions</h3><div>Although the mumps vaccination coverage rate increased following the program’s initiation, it remained below the level required for eradication.</div></div>","PeriodicalId":7621,"journal":{"name":"American journal of infection control","volume":"53 1","pages":"Pages 82-86"},"PeriodicalIF":3.8,"publicationDate":"2025-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142254193","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2025-01-01DOI: 10.1016/j.ajic.2024.08.001
Mary S. Kim MD , Aleksandra Sarcevic PhD , Genevieve J. Sippel BA , Kathleen H. McCarthy BS , Eleanor A. Wood BSE , Carmen Riley , Aaron H. Mun BS , Karen J. O’Connell MD, MEd , Peter T. LaPuma PhD, CIH, PE , Randall S. Burd MD, PhD
Background
Despite local and national recommendations, health care provider adherence to personal protective equipment (PPE) varied during the COVID-19 pandemic. Previous studies have identified factors influencing initial PPE adherence but did not address factors influencing behaviors leading to correction after initial nonadherence.
Methods
We conducted a retrospective video review of 18 pediatric resuscitations involving aerosol-generating procedures from March 2020 to December 2022 to identify factors associated with nonadherence correction. We quantified adherent and nonadherent providers, instances of PPE nonadherence, and time to correction. We also analyzed correction behaviors, including provider actions and correction locations.
Results
Among 434 providers, 362 (83%) were nonadherent with at least 1 PPE. Only 186 of 1,832 instances of nonadherence were corrected, primarily upon room entry and during patient care. Correction time varied by PPE type and nonadherence level (incomplete vs absent). Most corrections were self-initiated, with few reminders from other providers.
Discussion
Potential barriers to correction include a lack of social pressure and external reminders. Solutions include optimizing PPE availability, providing real-time feedback, and educating on double gloving.
Conclusions
Most providers were nonadherent to PPE requirements during high-risk infection transmission events. The low correction rate suggests challenges in promoting collective responsibility and maintaining protective behaviors during medical emergencies.
{"title":"Factors associated with correction of personal protective equipment nonadherence in a multidisciplinary emergency department setting: A retrospective video review","authors":"Mary S. Kim MD , Aleksandra Sarcevic PhD , Genevieve J. Sippel BA , Kathleen H. McCarthy BS , Eleanor A. Wood BSE , Carmen Riley , Aaron H. Mun BS , Karen J. O’Connell MD, MEd , Peter T. LaPuma PhD, CIH, PE , Randall S. Burd MD, PhD","doi":"10.1016/j.ajic.2024.08.001","DOIUrl":"10.1016/j.ajic.2024.08.001","url":null,"abstract":"<div><h3>Background</h3><div>Despite local and national recommendations, health care provider adherence to personal protective equipment (PPE) varied during the COVID-19 pandemic. Previous studies have identified factors influencing initial PPE adherence but did not address factors influencing behaviors leading to correction after initial nonadherence.</div></div><div><h3>Methods</h3><div>We conducted a retrospective video review of 18 pediatric resuscitations involving aerosol-generating procedures from March 2020 to December 2022 to identify factors associated with nonadherence correction. We quantified adherent and nonadherent providers, instances of PPE nonadherence, and time to correction. We also analyzed correction behaviors, including provider actions and correction locations.</div></div><div><h3>Results</h3><div>Among 434 providers, 362 (83%) were nonadherent with at least 1 PPE. Only 186 of 1,832 instances of nonadherence were corrected, primarily upon room entry and during patient care. Correction time varied by PPE type and nonadherence level (incomplete vs absent). Most corrections were self-initiated, with few reminders from other providers.</div></div><div><h3>Discussion</h3><div>Potential barriers to correction include a lack of social pressure and external reminders. Solutions include optimizing PPE availability, providing real-time feedback, and educating on double gloving.</div></div><div><h3>Conclusions</h3><div>Most providers were nonadherent to PPE requirements during high-risk infection transmission events. The low correction rate suggests challenges in promoting collective responsibility and maintaining protective behaviors during medical emergencies.</div></div>","PeriodicalId":7621,"journal":{"name":"American journal of infection control","volume":"53 1","pages":"Pages 30-35"},"PeriodicalIF":3.8,"publicationDate":"2025-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141905601","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2025-01-01DOI: 10.1016/j.ajic.2024.08.004
Isadora Caixeta da Silveira Ferreira , Izabella Clara de Brito Machado , Ralciane de Paula Menezes , Thiago Alves de Jesus , Mallu Santos Mendonça Lopes , Lúcio Borges de Araújo , Daniela Marques de Lima Mota Ferreira , Denise Von Dolinger de Brito Röder
Background
Analyze the incidence, risk factors, and fatality rates of bloodstream infections by Gram-negative bacteria (GNB-BSIs) in a Neonatal Intensive Care Unit.
Methods
This study employs a retrospective cohort design utilizing records of neonates admitted to the Neonatal Intensive Care Unit between January 2015 and June 2022.
Results
Among 1,495 neonates, 5.2% developed GNB-BSIs. The average incidence of infection per 1,000 patient-days was 2.9. Primary risk factors for infection that included preceeding carbapenem use were significant risk factors (odds ratio = 514.4; P < .01) and fourth-generation cephalosporins (odds ratio = 66; P < .01). Among the 85 GNB, 75.3% were fermenters, and 24.7% were non-fermenters. Of the isolates, 14.1% produced extended-spectrum beta-lactamase, and 2.3% carbapenem-resistant. Infection correlated with prolonged hospital stays (10-39 days) and increased mortality (10%-29.9%).
Conclusions
The high incidence of GNB-BSIs was exacerbated by the preceeding use of broad-spectrum antimicrobials, increasing the presence of multidrug-resistant isolates and fatality rates. These findings emphasize the importance of active surveillance.
{"title":"Challenges and trends in Gram-negative bacterial infections in critically neonates: A seven-and-a-half-year observational study","authors":"Isadora Caixeta da Silveira Ferreira , Izabella Clara de Brito Machado , Ralciane de Paula Menezes , Thiago Alves de Jesus , Mallu Santos Mendonça Lopes , Lúcio Borges de Araújo , Daniela Marques de Lima Mota Ferreira , Denise Von Dolinger de Brito Röder","doi":"10.1016/j.ajic.2024.08.004","DOIUrl":"10.1016/j.ajic.2024.08.004","url":null,"abstract":"<div><h3>Background</h3><div>Analyze the incidence, risk factors, and fatality rates of bloodstream infections by Gram-negative bacteria (GNB-BSIs) in a Neonatal Intensive Care Unit.</div></div><div><h3>Methods</h3><div>This study employs a retrospective cohort design utilizing records of neonates admitted to the Neonatal Intensive Care Unit between January 2015 and June 2022.</div></div><div><h3>Results</h3><div>Among 1,495 neonates, 5.2% developed GNB-BSIs. The average incidence of infection per 1,000 patient-days was 2.9. Primary risk factors for infection that included preceeding carbapenem use were significant risk factors (odds ratio<!--> <!-->=<!--> <!-->514.4; <em>P</em> < .01) and fourth-generation cephalosporins (odds ratio<!--> <!-->=<!--> <!-->66; <em>P</em> < .01). Among the 85 GNB, 75.3% were fermenters, and 24.7% were non-fermenters. Of the isolates, 14.1% produced extended-spectrum beta-lactamase, and 2.3% carbapenem-resistant. Infection correlated with prolonged hospital stays (10-39<!--> <!-->days) and increased mortality (10%-29.9%).</div></div><div><h3>Conclusions</h3><div>The high incidence of GNB-BSIs was exacerbated by the preceeding use of broad-spectrum antimicrobials, increasing the presence of multidrug-resistant isolates and fatality rates. These findings emphasize the importance of active surveillance.</div></div>","PeriodicalId":7621,"journal":{"name":"American journal of infection control","volume":"53 1","pages":"Pages 13-21"},"PeriodicalIF":3.8,"publicationDate":"2025-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141915850","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2025-01-01DOI: 10.1016/j.ajic.2024.08.007
Ivan Gilberto Macolla Bazan MD , Barbara Barros Pereira Lobo MD , Angelica Zaninelli Schreiber PhD , Roseli Calil PhD , Sergio Tadeu Martins Marba PhD , Jamil Pedro de Siqueira Caldas PhD
Background
In response to a 1995 outbreak of sepsis caused by multidrug-resistant (MR) Gram-negative bacteria (GNB), a Brazilian level III neonatal unit established a series of control and prevention measures. This study evaluated the long-term effects of these measures on late-onset neonatal sepsis (LONS) caused by MR bacteria from 2000 to 2020 and examined their impact on in-hospital mortality.
Methods
Newborns with LONS and positive cultures for Staphylococcus aureus, GNB, and Enterococcus sp were selected, adhering to Center for Desease Control and Prevention and local criteria. Joinpoint regression analysis was used to assess annual trends.
Results
Over the 21-year period, the overall LONS rate was 4.6%, showing a significant decline from 2000 to 2016 (P < .0001, slope -0.36). However, from 2016 to 2020, there was a non-significant increase in sepsis rates (slope +0.92, P = .08). MR sepsis were in 15.8% of sepsis cases and displayed a non-significant upward trend (slope +0.50, P = .08) with no major shifts. In-hospital mortality rates for MR and non-MR LONS showed no significant differences (P = .413).
Discussion
The study indicates a low prevalence of MR sepsis due to effective antimicrobial use and educational interventions.
Conclusions
MR sepsis prevalence remained low and stable, not increasing in-hospital mortality.
{"title":"Long-lasting effects of control measures on trends in incidence in neonatal late-onset sepsis due to multiresistant bacteria in a Brazilian neonatal unit","authors":"Ivan Gilberto Macolla Bazan MD , Barbara Barros Pereira Lobo MD , Angelica Zaninelli Schreiber PhD , Roseli Calil PhD , Sergio Tadeu Martins Marba PhD , Jamil Pedro de Siqueira Caldas PhD","doi":"10.1016/j.ajic.2024.08.007","DOIUrl":"10.1016/j.ajic.2024.08.007","url":null,"abstract":"<div><h3>Background</h3><div>In response to a 1995 outbreak of sepsis caused by multidrug-resistant (MR) Gram-negative bacteria (GNB), a Brazilian level III neonatal unit established a series of control and prevention measures. This study evaluated the long-term effects of these measures on late-onset neonatal sepsis (LONS) caused by MR bacteria from 2000 to 2020 and examined their impact on in-hospital mortality.</div></div><div><h3>Methods</h3><div>Newborns with LONS and positive cultures for <em>Staphylococcus aureus</em>, GNB, and <em>Enterococcus sp</em> were selected, adhering to Center for Desease Control and Prevention and local criteria. Joinpoint regression analysis was used to assess annual trends.</div></div><div><h3>Results</h3><div>Over the 21-year period, the overall LONS rate was 4.6%, showing a significant decline from 2000 to 2016 (<em>P</em> < .0001, slope -0.36). However, from 2016 to 2020, there was a non-significant increase in sepsis rates (slope +0.92, <em>P</em> = .08). MR sepsis were in 15.8% of sepsis cases and displayed a non-significant upward trend (slope +0.50, <em>P</em> = .08) with no major shifts. In-hospital mortality rates for MR and non-MR LONS showed no significant differences (<em>P</em> = .413).</div></div><div><h3>Discussion</h3><div>The study indicates a low prevalence of MR sepsis due to effective antimicrobial use and educational interventions.</div></div><div><h3>Conclusions</h3><div>MR sepsis prevalence remained low and stable, not increasing in-hospital mortality.</div></div>","PeriodicalId":7621,"journal":{"name":"American journal of infection control","volume":"53 1","pages":"Pages 22-29"},"PeriodicalIF":3.8,"publicationDate":"2025-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141987243","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
We developed a virtual reality (VR) education system and evaluated its clinical utility for promoting hand hygiene practices.
Methods
This prospective, 2-week, randomized controlled study conducted at Okayama University Hospital, Japan, from November 2023 to January 2024, involved 22 participants (18 medical students and 4 residents). A fully immersive 360° VR system (VIVE Pro Eye) using a head-mounted display and sensing gloves was used to develop 3 health care tasks in a virtual patient room—Environmental Cleaning, Gauze Exchange, and Urine Collection. After monitoring all participants' baseline usage data of portable hand-rubbing alcohol in the first week, we randomly assigned them into 1:1 groups (VR training and video lecture groups). The primary outcome was differences in hand-rubbed alcohol use before and after intervention.
Results
Before the intervention, alcohol use did not significantly differ between both groups. After the intervention, a significant increase in alcohol use was observed in the VR training group (median: 8.2 g vs 16.2 g; P = .019) but not in the video lecture group.
Conclusions
Our immersive 360° VR education system enhanced hand hygiene practices. Infection prevention and control practitioners and digital technology experts must collaborate to advance the development of superior educational devices and content.
{"title":"Effectiveness of sensing gloves–applied virtual reality education system on hand hygiene practice: A randomized controlled trial","authors":"Mahiro Izumi , Hideharu Hagiya MD, PhD , Yuki Otsuka MD, PhD , Yoshiaki Soejima MD, PhD , Shinnosuke Fukushima MD, PhD , Mitsunobu Shibata , Satoshi Hirota , Toshihiro Koyama PhD , Fumio Otsuka MD, PhD , Akio Gofuku PhD","doi":"10.1016/j.ajic.2024.08.003","DOIUrl":"10.1016/j.ajic.2024.08.003","url":null,"abstract":"<div><h3>Background</h3><div>We developed a virtual reality (VR) education system and evaluated its clinical utility for promoting hand hygiene practices.</div></div><div><h3>Methods</h3><div>This prospective, 2-week, randomized controlled study conducted at Okayama University Hospital, Japan, from November 2023 to January 2024, involved 22 participants (18 medical students and 4 residents). A fully immersive 360° VR system (VIVE Pro Eye) using a head-mounted display and sensing gloves was used to develop 3 health care tasks in a virtual patient room—Environmental Cleaning, Gauze Exchange, and Urine Collection. After monitoring all participants' baseline usage data of portable hand-rubbing alcohol in the first week, we randomly assigned them into 1:1 groups (VR training and video lecture groups). The primary outcome was differences in hand-rubbed alcohol use before and after intervention.</div></div><div><h3>Results</h3><div>Before the intervention, alcohol use did not significantly differ between both groups. After the intervention, a significant increase in alcohol use was observed in the VR training group (median: 8.2 g vs 16.2 g; <em>P</em> = .019) but not in the video lecture group.</div></div><div><h3>Conclusions</h3><div>Our immersive 360° VR education system enhanced hand hygiene practices. Infection prevention and control practitioners and digital technology experts must collaborate to advance the development of superior educational devices and content.</div></div>","PeriodicalId":7621,"journal":{"name":"American journal of infection control","volume":"53 1","pages":"Pages 65-69"},"PeriodicalIF":3.8,"publicationDate":"2025-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141911344","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2025-01-01DOI: 10.1016/j.ajic.2024.09.018
Karen K. Hoffmann MS, BSN, RN , Connie Steed MSN, RN , David Kremelberg PhD, MA , Richard Wenzel MD, MSc
{"title":"Response to the letter to the editor regarding “The efficacy of an alcohol-based nasal antiseptic versus mupirocin or an iodophor for preventing SSIs using a meta-analysis”","authors":"Karen K. Hoffmann MS, BSN, RN , Connie Steed MSN, RN , David Kremelberg PhD, MA , Richard Wenzel MD, MSc","doi":"10.1016/j.ajic.2024.09.018","DOIUrl":"10.1016/j.ajic.2024.09.018","url":null,"abstract":"","PeriodicalId":7621,"journal":{"name":"American journal of infection control","volume":"53 1","pages":"Pages 172-173"},"PeriodicalIF":3.8,"publicationDate":"2025-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142913576","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2025-01-01DOI: 10.1016/S0196-6553(24)00867-8
{"title":"Information for Authors","authors":"","doi":"10.1016/S0196-6553(24)00867-8","DOIUrl":"10.1016/S0196-6553(24)00867-8","url":null,"abstract":"","PeriodicalId":7621,"journal":{"name":"American journal of infection control","volume":"53 1","pages":"Pages A9-A10"},"PeriodicalIF":3.8,"publicationDate":"2025-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143151834","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2025-01-01DOI: 10.1016/j.ajic.2024.09.007
Seyed M. Karimi PhD , Md Yasin Ali Parh MS , Shaminul H. Shakib PhD , Hamid Zarei MS , Venetia Aranha MPH , Angela Graham MPH , Trey Allen PhD , Sirajum Munira Khan MS , Mana Moghadami MD , Demetra Antimisiaris PharmD , William Paul McKinney PhD , Bert Little PhD , YuTing Chen MPH, MS , Taylor Ingram MPH
Background
Age, race, ethnicity, and sex are important determinants of coronavirus disease of 2019 (COVID-19) outcomes. Older adults (65 years and older) are at the highest risk of COVID-19 morbidity and mortality. Analyzing their vaccine uptake by subclassifying demographics is rare and can assist vaccination policies. This study investigates COVID-19 dose 1 and 2 vaccine uptakes among them by race, ethnicity, and sex.
Methods
Immunization registry data were used to calculate temporal changes in older adults’ COVID-19 vaccine uptake by race, ethnicity, race-sex, and ethnicity-sex in Kentucky’s most populous county, Jefferson County, during the first 6 quarters of the COVID-19 vaccination program.
Results
By May 2022, the county’s Asian residents had the highest dose 1 and 2 vaccination rates (97.0% and 80.4%), then White residents (90.0% and 80.2%). Black residents had one of the lowest COVID-19 vaccination rates (87.3% and 77.3%). The rate among Hispanic residents (82.0% and 66.4%) was considerably lower than non-Hispanic residents (90.2% and 80.1%). The rates were consistently lower in males.
Conclusions
Racial, ethnic, and sex-based COVID-19 vaccine inequalities were largely maintained during the study period. Vaccine rollout practices and promotional programs should aim to boost the uptake of the COVID-19 vaccination among racial minority and male older adults.
{"title":"COVID-19 vaccine uptake inequality among older adults: A multidimensional demographic analysis","authors":"Seyed M. Karimi PhD , Md Yasin Ali Parh MS , Shaminul H. Shakib PhD , Hamid Zarei MS , Venetia Aranha MPH , Angela Graham MPH , Trey Allen PhD , Sirajum Munira Khan MS , Mana Moghadami MD , Demetra Antimisiaris PharmD , William Paul McKinney PhD , Bert Little PhD , YuTing Chen MPH, MS , Taylor Ingram MPH","doi":"10.1016/j.ajic.2024.09.007","DOIUrl":"10.1016/j.ajic.2024.09.007","url":null,"abstract":"<div><h3>Background</h3><div>Age, race, ethnicity, and sex are important determinants of coronavirus disease of 2019 (COVID-19) outcomes. Older adults (65 years and older) are at the highest risk of COVID-19 morbidity and mortality. Analyzing their vaccine uptake by subclassifying demographics is rare and can assist vaccination policies. This study investigates COVID-19 dose 1 and 2 vaccine uptakes among them by race, ethnicity, and sex.</div></div><div><h3>Methods</h3><div>Immunization registry data were used to calculate temporal changes in older adults’ COVID-19 vaccine uptake by race, ethnicity, race-sex, and ethnicity-sex in Kentucky’s most populous county, Jefferson County, during the first 6 quarters of the COVID-19 vaccination program.</div></div><div><h3>Results</h3><div>By May 2022, the county’s Asian residents had the highest dose 1 and 2 vaccination rates (97.0% and 80.4%), then White residents (90.0% and 80.2%). Black residents had one of the lowest COVID-19 vaccination rates (87.3% and 77.3%). The rate among Hispanic residents (82.0% and 66.4%) was considerably lower than non-Hispanic residents (90.2% and 80.1%). The rates were consistently lower in males.</div></div><div><h3>Conclusions</h3><div>Racial, ethnic, and sex-based COVID-19 vaccine inequalities were largely maintained during the study period. Vaccine rollout practices and promotional programs should aim to boost the uptake of the COVID-19 vaccination among racial minority and male older adults.</div></div>","PeriodicalId":7621,"journal":{"name":"American journal of infection control","volume":"53 1","pages":"Pages 115-125"},"PeriodicalIF":3.8,"publicationDate":"2025-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142279010","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}